Brief: Anthera Pharma reports additional mid-stage data on lupus drug
04/06/2015 21:30
June 4 (Reuters) - Anthera Pharmaceuticals Inc ANTH.O : * Press release - Anthera Pharmaceuticals announces additional data on patient-reported outcomes from phase 2b pearl-sc blisibimod study * Source text for Eikon ID:nGNXVDTCUa * Further company coverage ANTH.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Anthera Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman